Alliance Pharma PLC Appointment of Joint Corporate Broker (9074P)
September 06 2017 - 2:00AM
UK Regulatory
TIDMAPH
RNS Number : 9074P
Alliance Pharma PLC
06 September 2017
For immediate release 6 September 2017
ALLIANCE PHARMA PLC
("Alliance" or the "Company")
Appointment of Joint Corporate Broker
Alliance Pharma plc (AIM: APH), the specialty pharmaceutical
company, is pleased to announce the appointment of Investec Bank
plc as joint corporate broker to act alongside Numis Securities
Limited, the Company's Nominated Adviser and joint corporate
broker.
For further information:
+ 44 (0) 1249
Alliance Pharma plc 466966
John Dawson, Chief Executive
Officer
Peter Butterfield, Deputy Chief
Executive Officer
Andrew Franklin, Chief Financial
Officer
www.alliancepharma.co.uk
+ 44 (0) 20 7466
Buchanan 5000
Mark Court / Sophie Cowles
+ 44 (0) 20 7260
Numis Securities Limited 1000
Nominated Adviser: Michael
Meade / Freddie Barnfield
Corporate Broking: James Black
/ Toby Adcock
+44 (0) 20 7597
Investec Bank plc 5970
Corporate Finance: Daniel Adams
/ Ed Thomas
Corporate Broking: Patrick
Robb / Rob Baker
Notes to editors:
About Alliance Pharma
Alliance, founded in 1998, is an international speciality
pharmaceutical company based in Chippenham, Wiltshire, UK. The
Company has sales in more than 100 countries worldwide via direct
sales, joint ventures and a network of distributors. Alliance has a
strong track record of acquiring the rights to established niche
products and it currently owns or licenses the rights to
approximately 90 pharmaceutical and consumer healthcare products.
The Company continues to explore opportunities to expand its
product portfolio.
Alliance joined the AIM market of the London Stock Exchange in
December 2003 and trades under the symbol APH.
This information is provided by RNS
The company news service from the London Stock Exchange
END
APPBIGDCBUGBGRU
(END) Dow Jones Newswires
September 06, 2017 02:00 ET (06:00 GMT)
Alliance Pharma (LSE:APH)
Historical Stock Chart
From Mar 2024 to Apr 2024
Alliance Pharma (LSE:APH)
Historical Stock Chart
From Apr 2023 to Apr 2024